We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Randomized Controlled Double Blinding Study of Intradermal Acupuncture Treatment on Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00414505
Recruitment Status : Unknown
Verified May 2014 by Wonkwang University.
Recruitment status was:  Recruiting
First Posted : December 21, 2006
Last Update Posted : June 2, 2014
Korea Institute of Oriental Medicine
Information provided by:
Wonkwang University

Brief Summary:
The purpose of this study is to determine whether intradermal acupuncture is effective and safe in the treatment of obesity.

Condition or disease Intervention/treatment Phase
Obesity Device: Intradermal Acupuncture Treatment Phase 3

Detailed Description:
Recently the Studies of auricular acupuncture or Common Acupuncture on obesity have been conducted. Saam acupuncture, the Korean unique acupuncture, is famous with its high efficacy but not established by the scientific way yet. Thus, we tried a double-blind study on the effect of sa-am acupuncture on obesity using intradermal acupuncture.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 180 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Korea Institute of Oriental Medicine
Study Start Date : August 2006
Estimated Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acupuncture
U.S. FDA Resources

Primary Outcome Measures :
  1. Bio-body impedance methods

Secondary Outcome Measures :
  1. Cholesterol, Triglycerides, HDL LDL cholesterol

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • BMI>25, regular menstruation, volunteer

Exclusion Criteria:

  • symptomatic obesity, acupuncture treatment within 3 months, >120kg, pregnancy or breast-feeding, hemophilia, dementia, mental illness, arrhythmia, liver cirrhosis, renal failure, pace maker, diabete mellitus, tuberculosis, steroid taker,

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00414505

Contact: Sung-chul Kim 82-62-670-6442 kscndl@hanmail.net

Korea, Republic of
Wonkwang University Hospital Recruiting
Gwangju, Korea, Republic of, 503-310
Sponsors and Collaborators
Wonkwang University
Korea Institute of Oriental Medicine
Study Director: Sung-chul Kim, Ph.D. Dept. of Acupuncture & Moxibustion, Wonkwang University Hospital

ClinicalTrials.gov Identifier: NCT00414505     History of Changes
Other Study ID Numbers: K06070
First Posted: December 21, 2006    Key Record Dates
Last Update Posted: June 2, 2014
Last Verified: May 2014

Additional relevant MeSH terms:
Nutrition Disorders
Body Weight
Signs and Symptoms